Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Chin

Showing results (571-580 of 608) with videos related to

Pageof 61
Sort By:
Drugs - Real World Outcomes|January 12, 2026
Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)Pilar Escribano Subias, Murali M Chakinala, Kelly M Chin, et al.
The New England Journal of Medicine|December 25, 2015
Selexipag for the Treatment of Pulmonary Arterial HypertensionOlivier Sitbon, Richard Channick, Kelly M Chin, et al.
European Journal of Clinical Nutrition|February 17, 2005
Netherlands research programme weight gain prevention (NHF-NRG): rationale, objectives and strategiesS P J Kremers, T L S Visscher, J Brug, et al.
Frontiers in Cellular Neuroscience|December 5, 2019
Biosensors Show the Pharmacokinetics of S-Ketamine in the Endoplasmic ReticulumKallol Bera, Aron Kamajaya, Amol V Shivange, et al.
Bone Marrow Transplantation|February 24, 2025
A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosisEli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala, et al.
Molecular Cancer Therapeutics|August 28, 2020
Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 AntibodyAmir A Al-Khami, Sawsan Youssef, Yasmina Abdiche, et al.
Nature Genetics|June 15, 2026
Decoding common and rare noncoding variant effects across cellular and developmental contextsAndrew R Marderstein, Soumya Kundu, Evin M Padhi, et al.
Leukemia|December 22, 2006
Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19T Inukai, K Hirose, T Inaba, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 29, 1998
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)]M Tsurusawa, N Katano, T Hirota, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 24, 1998
[Bone marrow relapse in high-risk pediatric patients with acute lymphoblastic leukemia: a comparison of relapse times and initial clinical features of patients on different protocols. Children's Cancer and Leukemia Study group (CCLSG)]M Tsurusawa, N Katano, T Hirota, et al.
Pageof 61

Showing results (571-580 of 608) with videos related to

Sort By:
Pageof 61
Drugs - Real World Outcomes|January 12, 2026
Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)Pilar Escribano Subias, Murali M Chakinala, Kelly M Chin, et al.
The New England Journal of Medicine|December 25, 2015
Selexipag for the Treatment of Pulmonary Arterial HypertensionOlivier Sitbon, Richard Channick, Kelly M Chin, et al.
European Journal of Clinical Nutrition|February 17, 2005
Netherlands research programme weight gain prevention (NHF-NRG): rationale, objectives and strategiesS P J Kremers, T L S Visscher, J Brug, et al.
Frontiers in Cellular Neuroscience|December 5, 2019
Biosensors Show the Pharmacokinetics of S-Ketamine in the Endoplasmic ReticulumKallol Bera, Aron Kamajaya, Amol V Shivange, et al.
Bone Marrow Transplantation|February 24, 2025
A model for predicting day-100 stem cell transplant-related mortality in AL amyloidosisEli Muchtar, Angela Dispenzieri, Vaishali Sanchorawala, et al.
Molecular Cancer Therapeutics|August 28, 2020
Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 AntibodyAmir A Al-Khami, Sawsan Youssef, Yasmina Abdiche, et al.
Nature Genetics|June 15, 2026
Decoding common and rare noncoding variant effects across cellular and developmental contextsAndrew R Marderstein, Soumya Kundu, Evin M Padhi, et al.
Leukemia|December 22, 2006
Hypercalcemia in childhood acute lymphoblastic leukemia: frequent implication of parathyroid hormone-related peptide and E2A-HLF from translocation 17;19T Inukai, K Hirose, T Inaba, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 29, 1998
[Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)]M Tsurusawa, N Katano, T Hirota, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 24, 1998
[Bone marrow relapse in high-risk pediatric patients with acute lymphoblastic leukemia: a comparison of relapse times and initial clinical features of patients on different protocols. Children's Cancer and Leukemia Study group (CCLSG)]M Tsurusawa, N Katano, T Hirota, et al.
Pageof 61